About Weave
Weave Bio is the company behind the Weave Platform, an AI-native regulatory automation management solution transforming how regulatory dossiers are managed. Designed for pharmaceutical companies, biotech firms, CROs, and regulatory consultants, the Weave Platform streamlines document preparation and regulatory lifecycle management. It automates initial draft creation, extracts key insights, and seamlessly integrates study data into an AI-powered regulatory workflow.
The platform accelerates regulatory timelines, improves review quality, and ensures compliance with global regulatory standards. AutoIND, a widely adopted solution for preclinical IND preparation, has earned industry recognition, including the “Biotech AI Innovation of the Year” award. Expanding into clinical-stage submissions, AutoCT builds upon Weave’s foundation, creating a comprehensive AI workbench for the entire therapy lifecycle.
Backed by leading AI and life sciences investors, Weave is shaping the future of regulatory automation with an AI-driven, human-powered approach, enhancing efficiency, regulatory quality, and cost-effectiveness.
Our Investors
We partner with industry-leading experts to bring the very best technology and insights to the company
How we got here


December 2023
Seed funding from Innovation Endeavors and Magnetic Ventures

January 2024
Company launch with a focus on platform development

March 2024
Early release of AutoIND, our AI-native solution for IND preparation

June 2024
Full commercial launch of AutoIND for pharma and biotech customers

November 2024
Weave Bio Earns the 2024 “BioTech AI Innovation Of The Year” Award
